We recently reported that wearing unstable rocker shoes (Masai Barefoot Technology: MBT) may enhance recovery from marathon race-induced fatigue. However, this earlier study only utilized a questionnaire. In this study, we evaluated MBT utilizing objective physiological measures of recovery from marathon-induced muscle damages. Twenty-five university student novice runners were divided into two groups. After running a full marathon, one group wore MBT shoes (MBT group), and the control group (CON) wore ordinary shoes daily for 1 week following the race. We measured maximal isometric joint torque, muscle hardness (real time tissue elastography of the strain ratio) in the lower limb muscles before, immediately after, and 1, 3, and 8 days following the marathon. We calculated the magnitude of recovery by observing the difference in each value between the first measurement and the latter measurements. Results showed that isometric torques in knee flexion recovered at the first day after the race in the MBT group while it did not recover even at the eighth day in the CON group. Muscle hardness in the gastrocnemius and vastus lateralis showed enhanced recovery in the MBT group in comparison with the CON group. Also for muscle hardness in the tibialis anterior and biceps femoris, the timing of recovery was delayed in the CON group. In conclusion, wearing MBT shoes enhanced recovery in lower leg and thigh muscles from muscle damage induced by marathon running.

A number of autoimmune diseases are associated with the genotypes of human leukocyte antigen class II (HLA), some of which present peptides derived from self-proteins, resulting in clonal expansion of self-reactive T cells. Therefore, selective inhibition of self-peptide loading onto such disease-associated HLA could ameliorate the diseases. To effectively identify such compounds, in this study, we established, for the first time, a cell- and 96-well microplate-based high-throughput screening system for inhibitors of antigen presentation. A panel of DRB1 genes plus DRA*01:01 gene were expressed in HEK293T cells and in 3T3 cells, and their binding with biotinylated known self-antigen peptides was measured by flow cytometry. HLA-DR1 (DRB1*01:01) and DR15 (DRB1*15:01) showed a high affinity with myelin basic protein peptide (MBP83-98). Therefore, in 96-well plate wells, MBP83-99 was allowed to bind to DR1 or DR15 on 3T3 cells in competition with a test compound, and the HLA-bound peptide was detected by streptavidin-conjugated β-galactosidase, thereby identifying inhibitor compounds for rheumatoid arthritis or multiple sclerosis. Our assay system has a potential for broad applications, including designing peptide vaccines.

We sought to identify changes in individual muscle hardness after a full marathon and to track time-dependent changes using ultrasound strain elastography (SE). Twenty-one collegiate marathon runners were recruited. Muscle hardness (i.e., strain ratio, SR) was measured using SE for the rectus femoris (RF), vastus lateralis (VL), biceps femoris long head (BF), tibialis anterior (TA), gastrocnemius medial head (GM), and soleus (SOL) muscles at the following time points: pre (PRE), immediately post (POST), day-1 (D1), day-3 (D3), and day-8 (D8), after a full marathon. We found that the SR decreased after the full marathon (i.e., the muscle became harder), and that the lowest SR across all measured muscles was observed on D1. Although there was no difference in the magnitude of change in SR between the muscles of the thigh, that of the MG and SOL were significantly larger than that of the TA. Muscle hardness in the VL, BF, and SOL recovered at D8 (i.e., non-significant difference from PRE), whereas recovery of RF and GM hardness at D8 was not observed. Thus, the degree of change in muscle hardness does not occur uniformly within the lower extremity muscles. In particular, changes in muscle hardness of the TA after a full marathon is small compared with other muscles and time-dependent changes in each muscle varies during recovery. The features of muscle hardness identified in this study will be useful for coaches when mentoring runners on proper forms and for training advisers and therapists who seek to address deficiencies in running.

Green tea leaves fermented with Aspergillus luchuensis var kawachii kitahara (Cha-Koji) are a health food containing live A. luchuensis. In this study, we examined the effects of Cha-Koji on the immune system and the enteric environment. First, we designed a clinical trial; after ingesting Cha-Koji daily for 28 days, blood parameters and the fecal composition of the participants were analyzed. Similarly, mice were administered (oral administration) with Cha-Koji suspension or its vehicle for 14 days. Thereafter, both humans and mice were examined by analyzing their immune cell phenotypes and intestinal microbiota. Regulatory T cell (Treg) numbers were significantly increased after administering Cha-Koji. An increase of Clostridium subcluster XIVa, that were known to be rich in butyrate-producing bacterium, was observed in human feces, but not in mice. These results suggest that Cha-Koji has the ability to increase Treg production in both humans and mice, irrespective of the presence of enteric butyrate.

Background and Aims: It has been reported that low-level laser irradiation (LLLI) can influence muscle tissue by retarding attenuation of muscle tension. Since the efficacy of LLLI on the effects of muscle contraction remains unclear, we examined in an in vivo animal model whether LLLI affects both muscle tension and muscle hardness in a wavelength-dependent manner, using the rat gastrocnemius muscle. Material and Methods: Forty Sprague-Dawley adult rats were used. Under pentobarbital sodium anesthesia, their gastrocnemius muscle and tibial nerve were exteriorized. Diode LLLI systems delivering 3 wavelengths (405, 532, and 808 nm; 100 mW output) were used. Ten sets of tetanus (tetanic contractions) were delivered to the tibial nerve followed by a brief rest or LLLI for 15 s and an additional 7 sets of tetanus with an inter-stimulus interval of 5 min. The muscle tension and muscle hardness were measured with a tension transducer and hardness meter, respectively. Results: 405 nm LLLI did not influence either muscle tension or hardness. 532 nm LLLI significantly improved the maintenance of muscle tension compared with the 808 nm group (P<0.05). In contrast, 808 nm LLLI significantly improved the recovery from muscle hardness compared with the other groups (P<0.05). Conclusion: We conclude that LLLI has wavelength-dependent effects on the gastrocnemius muscle and LLLI at appropriate wavelengths and dosimetry offers potential in the treatment to relieve muscle tension or stiffness.